IFN-DCs generated from monocytes of glioblastoma patients were characterized by phenotypic profiles with delay of cell differentiation but expressed equal level molecules involved in antigen presentation (HLA-DR, CD86) to donor IFN-DCs as shown in Table 1 which confirmed our previous findings [25]. Here, CD86 is linked to glioblastoma.